Chembio Diagnostics Announces Approval of Zika, Dengue and Chikungunya Point-of-Care Multiplex Test by Brazil’s Health Regulatory Agency

NEXT STORY
Vaccinex, Inc. Summary of Key Data Presented at the 2019 Annual Meeting of the American Association for Cancer Research (AACR)
PREV STORY
Myriad Genetics Submits First Module of the Premarket Approval Application to FDA for the myChoice® HRD CDx Test
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clinical Trial Materials and Supplies Market Worth $25.9 Billion by 2027, Growing at a CAGR of 6% from 2019- Exclusive Report by Meticulous Research®

author_avatar
NASDAQ Market News

Coherus BioSciences Submits 351(k) Biologics License Application to U.S. Food and Drug Administration for CHS-1701 (Pegfilgrastim Biosimilar Candidate)

REDWOOD CITY, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ:CHRS), today ...

author_avatar
NASDAQ Market News

$20.4 Billion Worldwide In Vitro Diagnostics Quality Control Market – Key Players Include Bio-Rad Laboratories, Randox Laboratories & Thermo Fisher Scientific Among Others

author_avatar
NASDAQ Market News